Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jayaram

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Cancer Treatment Reports|August 1, 1979
Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA)H N Jayaram, D A Cooney, D T Vistica, et al.
Bioorganic & Medicinal Chemistry|September 24, 2008
Mycophenolic acid analogs with a modified metabolic profileLiqiang Chen, Daniel J Wilson, Nicholas P Labello, et al.
Life Sciences|November 6, 2001
Metabolism and disposition of the novel antileukaemic drug, benzamide riboside, in the isolated perfused rat liverA Salamon, B Hagenauer, T Thalhammer, et al.
Biochemical Pharmacology|August 15, 1976
DON, CONV and DONV-II. Inhibition of L-'asparagine synthetase in vivoR J Rosenbluth, D A Cooney, H N Jayaram, et al.
The International Journal of Biochemistry|January 1, 1980
Regulators of the metabolism of L-asparagine: a search for endogenous inhibitorsD A Cooney, M T Jones, H A Milman, et al.
Cancer Treatment Reports|October 1, 1976
Inhibitors of L-asparagine synthetase, in vitroD A Cooney, J S Driscoll, H A Milman, et al.
Current Medicinal Chemistry|April 23, 2002
The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide ribosideKrzysztof W Pankiewicz, Kyoichi A Watanabe, Krystyna Lesiak-Watanabe, et al.
Advances in Enzyme Regulation|January 1, 1987
Salvage pathways as targets of chemotherapyG Weber, H N Jayaram, K Pillwein, et al.
The Journal of Clinical Investigation|January 1, 1985
Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cellsD N Carney, G S Ahluwalia, H N Jayaram, et al.
Biochemical and Biophysical Research Communications|August 14, 1992
Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cellsH N Jayaram, K Gharehbaghi, N H Jayaram, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Cancer Treatment Reports|August 1, 1979
Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA)H N Jayaram, D A Cooney, D T Vistica, et al.
Bioorganic & Medicinal Chemistry|September 24, 2008
Mycophenolic acid analogs with a modified metabolic profileLiqiang Chen, Daniel J Wilson, Nicholas P Labello, et al.
Life Sciences|November 6, 2001
Metabolism and disposition of the novel antileukaemic drug, benzamide riboside, in the isolated perfused rat liverA Salamon, B Hagenauer, T Thalhammer, et al.
Biochemical Pharmacology|August 15, 1976
DON, CONV and DONV-II. Inhibition of L-'asparagine synthetase in vivoR J Rosenbluth, D A Cooney, H N Jayaram, et al.
The International Journal of Biochemistry|January 1, 1980
Regulators of the metabolism of L-asparagine: a search for endogenous inhibitorsD A Cooney, M T Jones, H A Milman, et al.
Cancer Treatment Reports|October 1, 1976
Inhibitors of L-asparagine synthetase, in vitroD A Cooney, J S Driscoll, H A Milman, et al.
Current Medicinal Chemistry|April 23, 2002
The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide ribosideKrzysztof W Pankiewicz, Kyoichi A Watanabe, Krystyna Lesiak-Watanabe, et al.
Advances in Enzyme Regulation|January 1, 1987
Salvage pathways as targets of chemotherapyG Weber, H N Jayaram, K Pillwein, et al.
The Journal of Clinical Investigation|January 1, 1985
Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cellsD N Carney, G S Ahluwalia, H N Jayaram, et al.
Biochemical and Biophysical Research Communications|August 14, 1992
Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cellsH N Jayaram, K Gharehbaghi, N H Jayaram, et al.
Pageof 19